DRAGONNCT07593404
Evaluation of a Novel Ocular Lubricating Eye Drop
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
- Primary completion moved earlier from Jan 2027 to Nov 2026
- Study completion moved earlier from May 2027 to Feb 2027
- Start date changed from estimate of May 2026 to May 28, 2026
- Study description revised
- Site details revised
- Notable Recruitment opened
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Number of Adverse Events
Timeframe: At the end of Part 1: 60 minutes after single drop monocular instillation and At the end of Part 2 (after 28 days of bilateral use)
Arms and interventions
Part 1Experimental
Part 1 Participants
Part 2Experimental
Part 2 Participants
Drugs: Part 2 ABR2 At least twice a day for 28 days, Part 1: ABR2 single dose in one eye
Sites
1 site in 1 country
- Centre for Ocular Research & Education, School of Optometry & Vision Science, University of WaterlooWaterloo, Ontario, Canada